Thomas Needham

Thomas Needham, MBA, has over 25 years of experience in venture capital, business development, corporate strategy, and executive management responsibilities in public and private life science companies. Mr. Needham is currently the Director and Head of the Biopharmaceutical practice at Broadview Ventures. Prior to joining Broadview Ventures, he held leadership roles in the biotechnology industry as Chief Business Officer at Merrimack Pharmaceuticals (Nasdaq: MACK), and Senior Vice President of Business Development at C4 Therapeutics (Nasdaq: CCCC). Mr. Needham previously spent 13 years as a venture capital investor as a Managing Director at Synthesis Capital and a Principal at Advent International.

Mr. Needham holds a BA from Bowdoin College and an MBA from Babson College’s F.W. Olin Graduate School of Business.